Johnson & Johnson Hit With $29 Million Verdict in Case Over Talc and Asbestos

16:24 EDT 14 Mar 2019 | The New York Times News

The company’s stock dipped on Thursday after a California jury found in favor of a woman who claimed that asbestos in the company’s talc-based powders caused her cancer.

More From BioPortfolio on "Johnson & Johnson Hit With $29 Million Verdict in Case Over Talc and Asbestos"